XML 34 R19.htm IDEA: XBRL DOCUMENT
v3.8.0.1

Note 11 - Share Option Plans | 12 Months Ended
--- | ---
Dec. 31, 2017
Notes to Financial Statements |
Disclosure of Compensation Related Costs, Share-based Payments [Text Block] | 11. Stock option plans: The Company ’s 1996 Stock Option Plan (the “1996 Plan”) was established for the benefit of the employees, officers, directors and certain consultants of the Company. The maximum number of common shares which may be set aside for issuance under the 1996 Plan was 2,787,500 shares, provided that the Board of Directors of the Company has the right, from time to time, to increase such number subject to the approval of the shareholders of the Company when required by law or regulatory authority. Generally, options issued under the 1996 Plan vest over a four -year period. The 1996 Plan expired on February 25, 2006; no options were issued from this plan after that date. On November 22, 2006, the shareholders of the Company approved the Company’s 2006 Equity Compensation Plan (the “2006 Plan”), which was amended and restated effective July 29, 2010 and which serves as a successor to the 1996 Plan. The 2006 Plan has been established for the benefit of the employees, officers, directors and certain consultants of the Company. The maximum number of common shares which have been set aside for issuance under the 2006 Plan is 1.25 million shares. On October 8, 2010, the 2006 Plan was amended to increase the number of shares which have been set aside for issuance by an additional 0.475 million shares to 1.725 million shares. In September 2015, the 2006 Plan was amended to increase the number of shares which have been set aside for issuance by an additional 0.75 million shares to 2.475 million shares. Generally, options issued under the 2006 Plan vest over a four -year period and have a term not exceeding seven years, except for automatic formula grants of non-qualified stock options, which vest after one year and have a five -year term. Prior to the September 2015 amendment to the 2006 Plan, automatic formula grants of non-qualified stock options vested immediately upon grant. Our current equity-based compensation plans include provisions that allow for the “net exercise” of stock options by all plan participants. In a net exercise, any required payroll taxes, federal withholding taxes and exercise price of the shares due from the option holder can be paid for by having the option holder tender back to the Company a number of shares at fair value equal to the amounts due. These transactions are accounted for by the Company as a purchase and retirement of shares. The fair value of each option grant is estimated on the date of grant using the Black-Scholes option-pricing model. Because option-pricing models require the use of subjective assumptions, changes in these assumptions can materially affect the fair value of the options. The assumptions presented in the table below represent the weighted average of the applicable assumption used to value stock options at their grant date. The Company calculates expected volatility based on historical volatility of the Company ’s common shares. The expected term, which represents the period of time that options granted are expected to be outstanding, is estimated based on historical exercise experience. The Company evaluated historical exercise behavior when determining the expected term assumptions. The risk-free rate assumed in valuing the options is based on the U.S. Treasury yield curve in effect at the time of grant for the expected term of the option. The Company determines the expected dividend yield percentage by dividing the expected annual dividend by the market price of Tucows Inc. common shares at the date of grant. The fair value of stock options granted during the years ended December 31, 2017, 2016 and 2015 was estimated using the following weighted average assumptions:
|  | Year ended December 31, |
|  | 201 7 |  |  | 201 6 |  |  | 201 5 |
Volatility |  |  | 41.6 | % |  |  | 66.1 | % |  |  | 44.1 | %
Risk-free interest rate |  |  | 1.8 | % |  |  | 1.3 | % |  |  | 1.3 | %
Expected life (in years) |  |  | 4.55 |  |  |  | 4.3 |  |  |  | 4.0 |
Dividend yield |  |  | — | % |  |  | — | % |  |  | — | %
The weighted average grant date fair value for options issued, with the exercise price equal to market value on the date of grant |  | $ | 20.08 |  |  | $ | 11.18 |  |  | $ | 7.40 |
Details of stock option transactions are as follows:
|  | Year ended December 31, |  |  | Year ended December 31, |  |  | Year ended December 31, |
|  | 201 7 |  |  | 201 6 |  |  | 201 5 |
|  | Number of shares |  |  | Weighted average exercise price per share |  |  | Number of shares |  |  | Weighted average exercise price per share |  |  | Number of shares |  |  | Weighted average exercise price per share |
Outstanding, beginning of period |  |  | 474,501 |  |  | $ | 12.67 |  |  |  | 513,366 |  |  | $ | 9.24 |  |  |  | 976,062 |  |  | $ | 5.41 |
Granted |  |  | 370,025 |  |  |  | 54.10 |  |  |  | 81,750 |  |  |  | 22.66 |  |  |  | 67,500 |  |  |  | 21.26 |
Exercised |  |  | (172,759 | ) |  |  | 7.88 |  |  |  | (109,963 | ) |  |  | 3.79 |  |  |  | (517,998 | ) |  |  | 3.53 |
Forfeited |  |  | (18,196 | ) |  |  | 37.70 |  |  |  | (9,902 | ) |  |  | 16.80 |  |  |  | (10,323 | ) |  |  | 13.30 |
Expired |  |  | — |  |  |  | — |  |  |  | (750 | ) |  |  | 3.76 |  |  |  | (1,875 | ) |  |  | 2.40 |
Outstanding, end of period |  |  | 653,571 |  |  |  | 36.69 |  |  |  | 474,501 |  |  |  | 12.67 |  |  |  | 513,366 |  |  |  | 9.24 |
Options exercisable, end of period |  |  | 243,771 |  |  | $ | 14.79 |  |  |  | 332,192 |  |  | $ | 10.08 |  |  |  | 321,155 |  |  | $ | 6.49 |
As of December 31, 2017, the exercise prices, weighted average remaining contractual life of outstanding options and intrinsic values were as follows:
|  |  |  |  |  |  |  |  |  |  |  | Options outstanding |  |  | Options exercisable |
Exercise price |  |  | Number outstanding |  |  | Weighted average exercise price per share |  |  | Weighted average remaining contractual life (years) |  |  | Aggregate intrinsic value |  |  | Number exercisable |  |  | Weighted average exercise price per share |  |  | Weighted average remaining contractual life (years) |  |  | Aggregate intrinsic value |
$ | 2.92 |  |  |  | - |  |  | $ | 8.92 |  |  |  | 91,133 |  |  | $ | 6.63 |  |  |  | 1.6 |  |  | $ | 5,779,404 |  |  |  | 91,133 |  |  | $ | 6.63 |  |  |  | 1.6 |  |  | $ | 5,779,404 |
$ | 10.16 |  |  |  | - |  |  | $ | 19.95 |  |  |  | 120,913 |  |  |  | 16.30 |  |  |  | 3.5 |  |  |  | 6,499,346 |  |  |  | 92,638 |  |  |  | 15.87 |  |  |  | 3.3 |  |  |  | 5,018,978 |
$ | 21.10 |  |  |  | - |  |  | $ | 27.53 |  |  |  | 81,000 |  |  |  | 23.65 |  |  |  | 4.2 |  |  |  | 3,758,393 |  |  |  | 55,000 |  |  |  | 24.61 |  |  |  | 3.8 |  |  |  | 2,499,313 |
$ | 35.25 |  |  |  | - |  |  | $ | 37.35 |  |  |  | 14,375 |  |  |  | 35.89 |  |  |  | 5.4 |  |  |  | 491,062 |  |  |  | 5,000 |  |  |  | 35.25 |  |  |  | 6.0 |  |  |  | 174,000 |
$ | 43.15 |  |  |  | - |  |  | $ | 47.00 |  |  |  | 18,500 |  |  |  | 44.19 |  |  |  | 6.1 |  |  |  | 478,400 |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |
$ | 53.20 |  |  |  | - |  |  | $ | 55.65 |  |  |  | 327,650 |  |  |  | 55.41 |  |  |  | 6.4 |  |  |  | 4,795,160 |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |
|  |  |  |  |  |  |  |  |  |  |  |  | 653,571 |  |  | $ | 36.69 |  |  |  | 4.9 |  |  | $ | 21,801,765 |  |  |  | 243,771 |  |  | $ | 14.79 |  |  |  | 2.8 |  |  | $ | 13,471,695 |
Total unrecognized compensation cost relating to unvested stock options at December 31, 201 7, prior to the consideration of expected forfeitures, is approximately $6.5 million and is expected to be recognized over a weighted average period of 3.0 years. The total intrinsic value of options exercised during the years ended December 31, 2017, 2016 and 2015 was $7.6 million, $2.4 million and $9.6 million, respectively. Cash received from the exercise of stock options during the years ended December 31, 2017, 2016 and 2015 was $0.2 million, $0.1 million and $0.8 million respectively. The Company recorded stock-based compensation amounting to $1.5 million, $0.8 million and $0.5 million for the years ended December 31, 2017, 2016 and 2015 respectively. Stock-based compensation has been included in operating expenses as follows:
|  | Year ended December 31, 2017 |  |  | Year ended December 31, 2016 |  |  | Year ended December 31, 2015 |
Network expenses |  | $ | 109,988 |  |  | $ | 21,704 |  |  | $ | 28,915 |
Sales and marketing |  |  | 571,682 |  |  |  | 236,063 |  |  |  | 188,035 |
Technical operations and development |  |  | 360,415 |  |  |  | 98,059 |  |  |  | 111,239 |
General and administrative |  |  | 414,487 |  |  |  | 443,608 |  |  |  | 197,836 |
|  | $ | 1,456,572 |  |  | $ | 799,434 |  |  | $ | 526,025 |

X
- Definition The entire disclosure for compensation-related costs for equity-based compensation, which may include disclosure of policies, compensation plan details, allocation of equity compensation, incentive distributions, equity-based arrangements to obtain goods and services, deferred compensation arrangements, employee stock ownership plan details and employee stock purchase plan details. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -URI http://asc.fasb.org/topic&trid=2228938 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 50 -URI http://asc.fasb.org/subtopic&trid=2208855 + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_DisclosureTextBlockAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration